Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life

European Journal of Endocrinology

Volumn 151, Issue 3, 2004, Pages 325-332

  Mahajan, Tripti ^a   Crown, Anna ^a   Checkley, Stuart ^b   Farmer, Anne ^b   Lightman, Stafford ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; GLUCOCORTICOID; HUMAN GROWTH HORMONE; HYDROCORTISONE; PLACEBO; RECOMBINANT GROWTH HORMONE;

ADULT; ARTHRALGIA; ARTICLE; ATYPICAL DEPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG RESPONSE; EMOTION; ENERGY; FEMALE; GROWTH HORMONE DEFICIENCY; HAND DISEASE; HUMAN; HYPOTHESIS; INTERVIEW; MALE; MORBIDITY; ONSET AGE; PARESTHESIA; PERIPHERAL EDEMA; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SLEEP DISORDER; SOCIAL ISOLATION; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CROSS-OVER STUDIES; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 4744376440     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1510325     Document Type: Article

References (34)

1. Carroll PV, Christ ER, Bengtsson B-A, Carlsson L, Christiansen JS, Clemmons D, Hintz R, Ho K, Laron Z, Sizonenko P, Sonksen PH, Tanaka T & Thorne M. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 382-395.
2. Drake WM, Howell SJ, Monson JP & Shalet SM. Optimizing GH therapy in adults and children. Endocrine Reviews 2001 22 425-450.
3. Burman P, Hetta J, Wide L, Mansson J-E, Ekman R & Karlsson FA. Growth hormone treatment affects brain neurotransmitters and thyroxine. Clinical Endocrinology 1996 44 319-324.
4. Johansson J-O, Larson G, Andersson M, Elmgren A, Hynsjo L, Lindahl A, Lundberg PA, Isaksson OG, Lindstedt S & Bengtsson BA. Treatment of growth hormone deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 1995 61 57-66.
5. Price LH, Charney DS, Delgado PL & Heninger GR. Serotonin function and depression: neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects. American Journal of Psychiatry 1991 148 1518-1525.
6. Puig-Antich J, Novacenko H, Davies M, Chambers WJ, Tabrizi MA, Krawiec V, Ambrosini PJ & Sachar EJ. Growth hormone secretion in prepubertal children with major depression. Archives of General Psychiatry 1994 41 455-460.
7. Birmaher B, Dahl RE, Williamson DE, Perel JM, Brent DA, Axelson DA, Kaufman J, Dorn LD, Stull S, Rao U & Ryan ND. Growth hormone secretion in children and adolescents at high risk for major depressive disorder. Archives of General Psychiatry 2000 57 867-872.
8. Bulow B, Hagmar L, Orbaek P, Osterberg K & Erfurth EM. High incidence of mental disorders, reduced mental well-being and cognitive function in hypopituitary women with GH deficiency treated for pituitary disease. Clinical Endocrinology 2002 56 183-193.
9. Holmes S & Shalet SM. Characteristics of adults who wish to enter a trial of growth hormone replacement. Clinical Endocrinology 1995 42 613-618.
10. Bryant J, Loveman E, Cave C, Chase D & Milne R. Endocrinology trial design: adverse event reporting in randomised controlled trials of recombinant human GH in GH deficient adults. Journal of Endocrinology 2002 175 545-552.
11. Wiren L, Whalley D, McKenna SP & Wilhelmsen L. Application of a disease-specific, quality-of-life measure (QoL-AGHDA) in growth hormone-deficient adults and a random population sample in Sweden: validation of the measure by Rasch analysis. Clinical Endocrinology 2000 52 143-152.
12. Barkan AL. The 'Quality of life-assessment of growth hormone deficiency in adults' questionnaire: can it be used to assess quality of life in hypopituitarism? Journal of Clinical Endocrinology and Metabolism 2001 86 1905-1907.
13. Mahajan T & Lightman S. A simple test for growth hormone deficiency in adults. Journal of Clinical Endocrinology and Metabolism 2000 85 1473-1476.
14. Goldberg D & Hillier V. A scaled version of the General Health Questionnaire. Psychological Medicine 1979 9 139-145.
15. Goodchild ME & Duncan-Jones P. Chronicity and the general health questionnaire. British Journal of Psychiatry 1985 146 55-61.
16. Wing J, Babor T, Brugha T, Burke J, Cooper J, Giel R, Jablenski A, Regier D & Sartorius N. Schedules for clinical assessment in neuropsychiatry. Archives of General Psychiatry 1990 47 589-593,
17. World Health Organisation. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. Geneva: World Health Organisation, 1993.
18. Hunt S & McEwen J. The development of a subjective health indicator. Sociology of Health and Illness 1980 2 231-246.
19. Hunt SM, McKenna SP, McEwen J, Williams J & Papp, E. The Nottingham Health Profile: subjective health status and medical consultations. Social Science and Medicine 1981 15 221-229.
20. Hamilton M. Development of a rating scale for primary depressive illness. British Journal of Social and Clinical Psychology 1967 6 278-296.
21. Montgomery S & Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 1979 134 382-389.
22. Astrom C & Trojaborg W Effect of growth hormone on human sleep energy Clinical Endocrinology 1992 36 241-245.
23. Murray RD & Shalet SM. Adult growth hormone replacement: lessons learned and future direction. Journal of Clinical Endocrinology and Metabolism 2002 87 4427-4428.
24. Rosen T, Wiren L, Wilhelmsen L, Wiklund I & Bengtsson B-A. Decreased psychological well-being in adult patients with growth hormone deficiency. Clinical Endocrinology 1994 40 111-116.
25. Peace KA, Orme SM, Sebastian JP, Thompson AR, Barnes S, Ellis AW & Belchetz PE. The effect of treatment variables on mood and social adjustment in adult patients with pituitary disease. Clinical Endocrinology 1997 46 445-450.
26. Lynch S, Merson S, Beshyah SA, Skinner E, Sharp P, Priest RG & Johnston DG. Psychiatric morbidity in adults with hypopituitarism. Journal of the Royal Society of Medicine 1994 87 445-447.
27. Page RCL, Hammersley MS, Burke CW & Wass JAH. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clinical Endocrinology 1997 46 401-406.
28. McGauley GA, Cuneo RC, Salomon F & Sonksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency Hormone Research 1990 33 (Suppl 4) 52-54.
29. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW & Hurley D. The Australian multicenter trial of growth hormone (GH) treatment in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 107-116.
30. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A & Shalet SM. Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clinical Endocrinology 1999 50 749-757.
31. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM & Monson JP. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 1998 83 3913-3919.
32. Gilchrist FJ, Murray RD & Shalet SM. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clinical Endocrinology 2002 57 363-370.
33. Whitehead HM, Boreham C, McIlrath EM, Sheridan B, Kennedy L, Atkinson AB & Hadden DR. Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo-controlled cross-over study. Clinical Endocrinology 1992 36 45-52.
34. Baum HBA, Katznelson L, Sherman JC, Biller BMK, Hayden DL, Schoenfeld DA, Cannistraro KE & Klibanski A. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency, Journal of Clinical Endocrinology and Metabolism 1998 83 3184-3189.